Efficacy and safety of canagliflozin in combination with insulin: a double-blind, randomized, placebo-controlled study in Japanese patients with type 2 diabetes mellitus
Crossref DOI link: https://doi.org/10.1186/s12933-016-0407-4
Published Online: 2016-06-18
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Inagaki, Nobuya
Harashima, Shin-ichi
Maruyama, Nobuko
Kawaguchi, Yutaka
Goda, Maki
Iijima, Hiroaki http://orcid.org/0000-0003-4621-2394
Funding for this research was provided by:
Mitsubishi Tanabe Pharma Corporation